vasoactive-intestinal-peptide and Hemorrhage

VIP has now been shown to produce an increase in renin release in a number of species, including humans. Our work suggests that VIP is capable of producing this effect by a direct action on the renin-secreting juxtaglomerular cells of the kidney. We have found no evidence to support the possibility that VIP produces this effect as a neurotransmitter in the kidney. In this regard, it should be noted that VIP has been identified as a cotransmitter primarily in cholinergic neurons. The kidney is thought to lack cholinergic innervation, and acetylcholine has no effect on renin secretion. We have explored two conditions where renin secretion is known to increase and found that circulating levels of VIP did not increase along with the increase in PRA. Thus, at least in hemorrhage and dietary sodium restriction, VIP does not appear to affect renin secretion through a humoral mechanism. There could be other untested situations where a humoral effect of VIP might come into play since we have shown that the whole animal is capable of increasing plasma VIP to levels that affect renin release. Studies employing recently developed VIP antagonists have the potential to determine in which physiological or pathological situations VIP contributes to the control of renin secretion. For example, in endotoxic shock, plasma levels of both VIP and PRA are significantly elevated. Could the increase in PRA be partly dependent on an action of circulating VIP?

Topics: Animals; Diet, Sodium-Restricted; Hemorrhage; Humans; Kidney; Kidney Tubules, Distal; Renin; Renin-Angiotensin System; Vasoactive Intestinal Peptide

Topics: Animals; Blood Transfusion; Hemorrhage; Histamine Release; Ischemia; Kidney; Male; Malondialdehyde; Mast Cells; Necrosis; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Vasoactive Intestinal Peptide

The effect of vasoactive intestinal peptide (VIP) on the activities of superoxide dismutase and catalase was investigated in renal tissues of rats exposed to 30% hemorrhage followed by reperfusion. In addition to enzyme activities, renal tissues were also histologically evaluated. Thirty percent hemorrhage had no significant effect on the activity of either enzyme. Reperfusion altered the activity of renal catalase but not of superoxide dismutase. On the other hand, administration of VIP (25 ng.kg-1) together with shed blood retransfusion protected the renal tissue from hemorrhagic ischemia-reperfusion injury without increasing superoxide dismutase and catalase activity. These results seem to be related either to the inhibitory effect of VIP on production or quenching activity of some reactive oxygen species. In conclusion, VIP may be a novel promising therapeutic approach toward defenses against hemorrhagic ischemia-reperfusion injury as an antioxidant.

Topics: Analysis of Variance; Animals; Catalase; Female; Hemorrhage; Ischemia; Kidney; Male; Rats; Reperfusion; Superoxide Dismutase; Vasoactive Intestinal Peptide

We have previously shown that vasoactive intestinal peptide (VIP) is a renin-stimulating factor both in vivo and in vitro. In the present investigation we sought to determine whether VIP exerted this effect by a neural or humoral mechanism. To test for a neural effect, the renal nerves were stimulated on one side for 30 min in anesthetized dogs, and plasma VIP and renin levels were determined in the renal venous effluent. The stimulation significantly increased plasma renin activity in arterial and renal venous plasma but had no effect on VIP concentrations. A humoral action was tested in two ways. First, plasma renin activity was measured before and after elevating circulating levels of endogenously produced VIP using intravenous neostigmine (0.07 mg/kg) in control, renal-denervated, and propranolol-pretreated animals. In all three groups, the elevated plasma level of VIP was associated with a significant increase in plasma renin activity. Second, plasma levels of VIP were determined in conscious dogs with elevated plasma renin activity produced by either a low-salt diet or hemorrhage. In both cases, plasma renin activity was significantly elevated as expected, but plasma levels of VIP were unchanged. These data suggest that the effects of VIP on renin secretion are not mediated by release of the peptide from the renal nerves, the circulating level of endogenously produced VIP can be elevated sufficiently to stimulate renin secretion, but a humoral role of VIP in the elevated plasma renin activity produced by low-salt diet or hemorrhage seems unlikely.+

Topics: Animals; Blood Pressure; Diet, Sodium-Restricted; Dogs; Electric Stimulation; Female; Hemorrhage; Kidney; Male; Neostigmine; Propranolol; Renin; Renin-Angiotensin System; Sodium; Stimulation, Chemical; Vasoactive Intestinal Peptide